The promising potential of terapia con células madre has given rise to initially encouraging clinical results. While doctors in North America and Western Europe continue to study terapia con células madre, rigorously evaluating its potential benefits, necessity triggered application of this science in clinical practice in Ukraine almost 20 twenty years ago. Nearly a million people in the Kiev area alone experienced adverse health effects when radioactive dust settled across Ukraine following the nuclear reactor explosion at Chernobyl in April 1986. Faced with treating patients suffering from conditions ranging from diabetes to blood anemia and cancer, the Ukrainian government began funding new research into repairing tissue and blood cells that would produce results quickly. Doctors turned to adult terapia con células madre, and they claim to have been successfully treating patients there since the Chernobyl disaster. Scientists in other countries are skeptical about this success because there are no published random clinical trials – the gold standard of medical research – regarding the positive or negative effects of terapia con células madre. Many countries have banned some forms of stem cell research, while scientists in other countries strive to become leaders in this controversial area of exploration.
Terapia con células madre
Terapia con células madre para el hígado
Los pacientes con cirrosis descompensada tienen que optar en su mayoría por un trasplante de hígado., pero la disponibilidad limitada de órganos de donantes y el alto costo resultan en una alta mortalidad en la lista de espera . Las células madre del propio cuerpo ayudan Leer más…
